Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey
Europace · 2024
DOI: 10.1093/europace/euae112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Teodor Serban und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Cardiomyopathies. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Arrhythmia-induced cardiomyopathy (AiCM) represents a subtype of acute heart failure (HF) in the context of sustained arrhythmia. Clear definitions and management recommendations for AiCM are lacking. The European Heart Rhythm Association Scientific Initiatives Committee (EHRA SIC) conducted a survey to explore the current definitions and management of patients with AiCM among European and non-European electrophysiologists. Methods and results A 25-item online questionnaire was developed and distributed among EP specialists on the EHRA SIC website and on social media between 4 September and 5 October 2023. Of the 206 respondents, 16% were female and 61% were between 30 and 49 years old. Most of the respondents were EP specialists (81%) working at university hospitals (47%). While most participants (67%) agreed that AiCM should be defined as a left ventricular ejection fraction (LVEF) impairment after new onset of an arrhythmia, only 35% identified a specific LVEF drop to diagnose AiCM with a wide range of values (5–20% LVEF drop). Most respondents considered all available therapies: catheter ablation (93%), electrical cardioversion (83%), antiarrhythmic drugs (76%), and adjuvant HF treatment (76%). A total of 83% of respondents indicated that adjuvant HF treatment should be started at first HF diagnosis prior to antiarrhythmic treatment, and 84% agreed it should be stopped within six months after LVEF normalization. Responses for the optimal time point for the first LVEF reassessment during follow-up varied markedly (1 day–6 months after antiarrhythmic treatment).
Conclusion
This EHRA Survey reveals varying practices regarding AiCM among physicians, highlighting a lack of consensus and heterogenous care of these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, University Hospital Basel, University of Basel, Petersgraben 4, 4031 Basel, Switzerland.
- Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Spitalstrasse 2, 4056 Basel, Switzerland.
- Department of Cardiology, St Bartholomew's Hospital, London, UK.
- Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Padova, Italy.
- Department of Cardiology, University Hospital of Verona, Verona, Italy.
- Department of Cardiology, Medical Centre Teknon, Grupo Quironsalud, Barcelona, Spain.
ORCID-Profile: Teodor Serban, Patrick Badertscher, Jeanne du Fay de Lavallaz, Rui Providencia, Federico Migliore, Giacomo Mugnai, Diego Penela, Laura Perrotta, Michael Kühne, Christian Sticherling, Kyoung-Ryul Julian Chun
Zitieren
APA
Serban, T., Badertscher, P., du Fay de Lavallaz, J., Providencia, R., Migliore, F., Mugnai, G., Penela, D., Perrotta, L., Kühne, M., Sticherling, C., & Chun, K. J. (2024). Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey. Europace. https://doi.org/10.1093/europace/euae112
Vancouver
Serban T, Badertscher P, du Fay de Lavallaz J, Providencia R, Migliore F, Mugnai G, et al. Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey. Europace. 2024. doi:10.1093/europace/euae112
BibTeX
@article{Serban2024,
author = {Serban, Teodor and Badertscher, Patrick and du Fay de Lavallaz, Jeanne and Providencia, Rui and Migliore, Federico and Mugnai, Giacomo and Penela, Diego and Perrotta, Laura and Kühne, Michael and Sticherling, Christian and Chun, Kyoung-Ryul Julian},
title = {Definition and management of arrhythmia-induced cardiomyopathy: findings from the European Heart Rhythm Association survey},
journal = {Europace},
year = {2024},
doi = {10.1093/europace/euae112}
}
EUVIMED